Clinical Trials
36 trialsNCT07604909 2026-05-22
A Phase II Randomized Trial of Serplulimab With Second-Line Chemo/Targeted Therapy for Early Relapse Colorectal Cancer After Adjuvant Chemotherapy
Fudan University
Phase 2 Recruiting
NCT06475352 2026-04-23
FUDOSE
UNICANCER
Phase 2 Recruiting
NCT06330064 2026-02-12
A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02)
Daiichi Sankyo
Phase 2 Recruiting
NCT07337421 2026-01-13
Efcacy and Safety of Postoperative Adjuvant Hepatic Arterial Infusion Chemotherapy With mFOLFOX in Hepatocellular Carcinoma With High-risk Recurrence Factors
Northern Jiangsu People's Hospital
Phase 2 Recruiting
NCT07337460 2026-01-13
Efficacy and Safety of Icaritin Combined With mFOLFOX in Postoperative HCC With High-risk Recurrence Factors
Northern Jiangsu People's Hospital
Phase 2 Recruiting
NCT02151084 2025-12-16
A Study of Different Dosing Schedules of Selumetinib With Cisplatin/Gemcitabine (CIS/GEM) Versus CIS/GEM Alone in Biliary Cancer
University Health Network, Toronto
Phase 2 Active not recruiting
NCT04204850 2025-12-03
Cabozantinib to Treat Recurrent Liver Cancer Post Transplant
University Health Network, Toronto
Phase 2 Recruiting
NCT01781728 2025-07-20
Palliative Stereotactic Radiation for Pancreatic or Periampullary Adenocarcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT01493206 2025-05-31
A Prospective Single Arm Study of Intraoperative Radiotherapy for Locally Advanced or Recurrent Rectal Cancer
Peter MacCallum Cancer Centre, Australia
Phase 2 Completed
NCT06420440 2025-05-01
Neoadjuvant Therapy in Patients With Resectable HCC Screened by a Multimodal Deep Learning Model
Tongji Hospital
Phase 2 Recruiting
NCT06914674 2025-04-06
SPTP
Fudan University
Phase 2 Recruiting
NCT04791228 2025-01-01
A Pilot Study of Thermodox and MR-HIFU for Treatment of Relapsed Solid Tumors
Children's National Research Institute
Phase 2 Withdrawn
NCT05476796 2024-10-24
LOGICAN
UNICANCER
Phase 2 Recruiting
NCT03439085 2024-07-09
DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112 and Durvalumab in Treating Patients With Recurrent or Metastatic Human Papillomavirus Associated Cancers
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT06193733 2024-01-05
Dendritic Cell Vaccination to Prevent Hepatocellular Carcinoma Recurrence After Liver Resection-phase II Clinical Trial
Chang Gung Memorial Hospital
Phase 2 Not yet recruiting
NCT04889742 2023-12-26
HETERERO
Charite University, Berlin, Germany
Phase 2 Not yet recruiting
NCT06041490 2023-09-18
Adjuvant Therapy for High-risk Hepatocellular Carcinoma Post Liver Transplantation
Peking Union Medical College Hospital
Phase 2 Not yet recruiting
NCT01684098 2023-06-22
Safety and Efficacy of FalateScan (Technetium Tc 99m EC20) in Patients With Known Suspected Recurrent or Metastatic Cancer From a Solid Tumor
Endocyte
Phase 2 Completed
NCT03999658 2023-05-01
A Study of STI-3031 (an Anti-PD-L1 Antibody) in Patients With Selected Relapsed/Refractory Malignancies
Sorrento Therapeutics, Inc.
Phase 2 Withdrawn
NCT05816980 2023-04-18
Re-RAD-I
Aarhus University Hospital
Phase 2 Completed
NCT05807984 2023-04-11
Re-irradiation Therapy of Locally Recurrent Rectal Cancer With Carbon Ion
Shanghai Proton and Heavy Ion Center
Phase 2 Not yet recruiting
NCT05732662 2023-02-17
SBRT Combined With AK104 to Treatment Relapsed or Metastatic ESCC
The First People's Hospital of Changzhou
Phase 2 Not yet recruiting
NCT04981665 2022-01-05
A Study to Evaluate TACE Sequential Tislelizumab as Adjuvant Therapy in Participants With HCC at High Risk of Recurrence After Curative Resection
Zhejiang University
Phase 2 Unknown
NCT03913182 2020-02-05
Apatinib in the Treatment of Recurrence or Metastasis of Esophageal Cancer
Shanghai Chest Hospital
Phase 2 Unknown
NCT01283204 2019-01-29
Trial of 4-regimen (SP, FL/Tax, FL/Doc, FOLFOX) in Patients With Recurrent or Metastatic Gastric Cancer
Yonsei University
Phase 2 Completed
NCT03585673 2018-07-17
DOSE
Dong-A University Hospital
Phase 2 Unknown
NCT02625272 2017-11-08
A Novel Technique of HALS With CME and CVL for RCC
West China Hospital
Phase 2 Unknown
NCT00386516 2017-08-01
Study to Test the Benefit and Safety of GM-CT-01 in Combination With 5-FU to Treat Bile Duct and Gall Bladder Cancer
Galectin Therapeutics Inc.
Phase 2 Withdrawn
NCT01095523 2017-07-02
Prospective Randomized Trial Evaluating Mandatory Second Look Surgery With HIPEC and CRS vs. Standard of Care in Subjects at High Risk of Developing Colorectal Peritoneal Metastases
National Institutes of Health Clinical Center (CC)
Phase 2 Withdrawn
NCT01172548 2017-05-31
INV555
Novartis
Phase 2 Completed
NCT01364493 2017-05-09
A Study to Evaluate the Efficacy and Safety of Trastuzumab in Combination With Capecitabine and Oxaliplatin as First-line Chemotherapy for Inoperable, Locally Advanced or Recurrent and/or Metastatic Gastric Cancer
Peking University
Phase 2 Completed
NCT01441310 2017-01-09
SNNS
Seoul National University Bundang Hospital
Phase 2 Completed
NCT00864513 2015-12-08
Study of Pemetrexed for Second-Line Pancreas Cancer
Georgetown University
Phase 2 Terminated
NCT00961077 2009-08-18
Attenuated SOX as First-line Treatment in Elderly Patients With Relapsed or Metastatic Gastric Cancer
Soonchunhyang University Hospital
Phase 2 Unknown
NCT00510107 2007-08-01
Weekly Docetaxel Plus Cisplatin or Oxaliplatin for AGC
Gachon University Gil Medical Center
Phase 2 Unknown
NCT00154726 2005-11-22
Paclitaxel-HDFL for Locally Advanced and Recurrent/Metastatic Gastric Cancers
National Taiwan University Hospital
Phase 2 Completed